CVS Health
CVS
1,531 hedge funds and large institutions have $68.2B invested in CVS Health in 2017 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 598 increasing their positions, 718 reducing their positions, and 78 closing their positions.
1% more capital invested
Capital invested by funds: $67.6B → $68.2B (+$585M)
0.03% more ownership
Funds ownership: 82.51% → 82.54% (+0.03%)
1% less funds holding
Funds holding: 1,552 → 1,531 (-21)
7% less funds holding in top 10
Funds holding in top 10: 71 → 66 (-5)
10% less first-time investments, than exits
New positions opened: 70 | Existing positions closed: 78
17% less repeat investments, than reductions
Existing positions increased: 598 | Existing positions reduced: 718
21% less call options, than puts
Call options by funds: $457M | Put options by funds: $579M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$308M |
| 2 |
BlackRock
New York
|
+$235M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$146M |
| 4 |
JP Morgan Chase
New York
|
+$141M |
| 5 |
KP
Kiltearn Partners
Edinburgh,
United Kingdom
|
+$116M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Magellan Asset Management
Sydney,
Australia
|
-$1.06B |
| 2 |
State Street
Boston,
Massachusetts
|
-$117M |
| 3 |
Two Sigma Advisers
New York
|
-$104M |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$98.3M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$91M |
CVS Hedge Fund Activity: Q3 2017 in Review
1,531 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2017, worth a combined $68.2B — up 0.86% from $67.6B a quarter earlier.
Sellers outnumbered buyers: 78 funds closed out of CVS and 70 opened new positions — a net loss of 8 holders — while 718 trimmed existing stakes and 598 added.
The largest buyer was Fidelity Investments, adding an estimated $308M. The largest seller was Magellan Asset Management, cutting an estimated $1.06B.
- 1,531 institutional investors held CVS Health (CVS) as of Q3 2017, down from 1,552 in Q2 2017.
- Funds reported $68.2B of CVS Health stock for Q3 2017, up 0.86% quarter-over-quarter.
- 70 funds opened new CVS Health positions in Q3 2017 and 78 closed out, a net change of -8 holders.
- The largest CVS Health buyer in Q3 2017 was Fidelity Investments, an estimated $308M added.
- The largest CVS Health seller in Q3 2017 was Magellan Asset Management, an estimated $1.06B sold.
Based on aggregated 13F filings for Q3 2017.